Bio-Rad Labs (BIO) Reports Q4 EPS of $1.34
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $379.57 +0.59%
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.34, may not compare to the analyst estimate of $1.18. Revenue for the quarter came in at $598.2 million versus the consensus estimate of $593.41 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
